



















































































































(AT)	in	ml	kg-1	min-1,	Peak	V! O2	in	ml	kg-1	min-1	and	V! E/	V! CO2.	The	following	discriminatory	
thresholds	for	these	CPET	variables	were	selected	a	priori	based	on	published	studies	shown	to	
identify	those	at	increased	risk	of	morbidity	and	death	among	patients	undergoing	major	non-































































































































































































































































































Age	 73.4	(44	–	90)	 70.5	(48	–	86)	 75.0	(44	–	90)	 <0.001	 0	(0.0)	
Female	 87	(17.2)	 39	(21.9)	 48	(14.7)	 0.053	 1	(0.2)	
Diabetes	 50	(9.9)	 15	(9.0)	 35	(11.9)	 0.441	 47	(9.3)	
Ischaemic	heart	disease	 214	(42.3)	 51	(31.5)	 163	(55.8)	 <0.001	 52	(10.3)	
Treated	hypertension	 178	(35.2)	 80	(46.5)	 98	(31.0)	 <0.001	 18	(3.6)	
Antiplatelet	medication	 330	(65.2)	 124	(70.1)	 206	(63.8)	 0.187	 6	(1.2)	
Statin	 324	(64.0)	 123	(69.5)	 201	(62.2)	 0.126	 6	(1.2)	
Haemoglobin	g	l-1	 13.3	±	1.8	 13.6	±	1.9	 13.2	±	1.8	 0.022	 14	(2.8)	
Urea	>7.5mmol	l-1	 7.4	±	3.3	 7.1	±	2.5	 7.6	±	3.6	 0.407	 13	(2.6)	
Creatinine	>	120µmol	l-1	 103.7	±	51.6	 99.3	±	31.8	 106.0	±	59.6	 0.099	 9	(1.8)	
Supra/juxta	renal	 59	(11.7)	 46	(26.0)	 13	(4.2)	 <0.001	 20	(4.0)	
AAA	diameter	(mm)	 63.1	±	10.1	 64.0	±	11.0	 62.5	±	9.5	 0.125	 32	(6.3)	
AT	<	10.2	ml	kg-1	min-1	 189	(37.4)	 46	(27.2)	 143	(50.3)	 <0.001	 53	(10.5)	
V! E/	V! CO2	at	AT	>42	 80	(15.8)	 17	(10.0)	 63	(19.3)	 0.006	 2	(0.4)	
Peak	V! O2	<	15	ml	kg-1	min-1	 256	(50.6)	 66	(37.1)	 190	(57.9)	 <0.001	 0	(0.0)	
ICI	 46	(9.1)	 12	(6.7)	 34	(10.5)	 0.222	 3	(0.6)	
≥2	sub-threshold	CPET	values	 213	(42.1)	 49	(27.3)	 164	(50.2)	 <0.001	 0	(0.0)	















































V! E/	V! CO2>	42	at	AT	 1.628	(1.009-2.627)	 0.046	
Peak	VO2	<	15	(ml	kg-1	min-1)	 1.676	(1.002-2.803)	 0.049	
HR,	hazard	ratio;	CI,	confidence	interval;	AT,	anaerobic	threshold;	V! E/	V! CO2,	ventilatory	equivalents	
for	carbon	dioxide;	peak	V! O2,	peak	oxygen	consumption	
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LEGENDS	TO	ILLUSTRATIONS	
Figure	1:	Kaplan-Meier	graph	for	survival	following	elective	AAA	repair	by	procedure	type.	Survival	is	
initially	worse	in	the	open	AAA	repair	group	with	the	survival	curves	crossing	at	approximately	6	
months	and	survival	subsequently	worse	in	the	EVAR	group	(P	<	0.001,	log	rank	test).		
Figure	2:	Kaplan-Meier	graph	for	survival	following	elective	AAA	repair	by	the	number	of	sub-
threshold	CPET	values	(P	<	0.001,	log	rank	test).	
Figure	3:	Plot	of	Peak	VO2	against	AT	for	pairwise-complete	records.	Green	triangles	indicate	the	
patient	was	alive	at	the	end	of	follow-up;	blue	circles	indicate	that	death	occurred	during	follow-up.	
The	vertical	dashed	lines	on	the	bottom	axis	indicate	the	measured	Peak	VO2	for	patients	who	did	
not	have	a	recorded	AT	measurement	(coloured	as	appropriated).	The	black	dotted	line	indicates	the	
linear	model	regression	line	(Pearson’s	sample	correlation	coefficient	r	=	0.81;	regression	slope	=	
0.508	(P	<	0.001)).	The	red	lines	delineate	the	thresholds	used	to	dichotomise	sub-threshold	CPET	
values.	
	
 
